Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange postpones the first pre-IPO transaction

6/20/24 MOEX

Moscow Exchange postpones the first pre-IPO transaction

6/20/24 OTCI

VK to launch VK Tutoria tutoring service

6/20/24 VKCO

Shareholders of Rosseti Volga approved dividends for 2023

6/20/24 MRKV

SPB Exchange goes to the East

6/20/24 SPBE

Yuzhuralzoloto will place 2-4% of additional issue shares

6/20/24 UGLD

HeadHunter opened Grid for a wide range of users

6/20/24 HEAD

Steppe will produce agricultural machinery

6/20/24 AFKS

X5 Retail Group may re-launch alkomarkets

6/20/24 X5

Novatek plans LNG projects in Vietnam

6/20/24 NVTK